Addressing Antibiotic Resistance with Novel Drug Formulations

Keywords

Antibiotic resistance
novel drug formulations
combination therapies
nanomedicine
antimicrobial peptides
bacteriophage therapy

Abstract

Antibiotic resistance (ABR) represents a critical global health challenge, posing significant risks to effective disease management. In recent years, the evolution of antibiotic-resistant pathogens has outpaced the development of new antibiotics, leading to increased mortality and prolonged hospital stays. This article explores novel drug formulations aimed at combating antibiotic resistance. Specifically, it discusses the use of combination therapies, nanomedicine, and alternative antimicrobial agents. These novel formulations enhance the efficacy of existing antibiotics and provide new pathways to overcome resistant strains. The article also reviews current research on antimicrobial peptides, bacteriophage therapy, and drug delivery systems that target resistant bacteria. By embracing innovative strategies in drug formulation, we can mitigate the impact of antibiotic resistance and improve clinical outcomes.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 Dr. Ayesha Khan (Author)